Limits...
Incidence and clinical features of drug-induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registry.

Satoh T, Gemma A, Kudoh S, Sakai F, Yamaguchi K, Watanabe T, Ishiguro M, Inoshiri S, Izawa M, Sugihara K, Sakata Y - Jpn. J. Clin. Oncol. (2014)

Bottom Line: We analyzed time to onset, patient characteristics and factors associated with mortality.Fourteen patients received steroid pulse therapy.There was no particular trend in the time to onset.

View Article: PubMed Central - PubMed

Affiliation: Department of Medical Oncology, Kinki University, Osakasayama, Osaka Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka taroh@cfs.med.osaka-u.ac.jp.

Show MeSH

Related in: MedlinePlus

Time to the onset of DLI from the start of cetuximab administration.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4214246&req=5

HYU128F2: Time to the onset of DLI from the start of cetuximab administration.

Mentions: The median time to the onset of DLI from the start of cetuximab therapy was 101 days (range, 17–431 days; Fig. 2). DLI occurred within 30 days of starting cetuximab therapy in three patients, from 31 to 60 days in five patients, from 61 to 90 days in four patients, and on Day 91 or later in 12 patients.Figure 2.


Incidence and clinical features of drug-induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registry.

Satoh T, Gemma A, Kudoh S, Sakai F, Yamaguchi K, Watanabe T, Ishiguro M, Inoshiri S, Izawa M, Sugihara K, Sakata Y - Jpn. J. Clin. Oncol. (2014)

Time to the onset of DLI from the start of cetuximab administration.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4214246&req=5

HYU128F2: Time to the onset of DLI from the start of cetuximab administration.
Mentions: The median time to the onset of DLI from the start of cetuximab therapy was 101 days (range, 17–431 days; Fig. 2). DLI occurred within 30 days of starting cetuximab therapy in three patients, from 31 to 60 days in five patients, from 61 to 90 days in four patients, and on Day 91 or later in 12 patients.Figure 2.

Bottom Line: We analyzed time to onset, patient characteristics and factors associated with mortality.Fourteen patients received steroid pulse therapy.There was no particular trend in the time to onset.

View Article: PubMed Central - PubMed

Affiliation: Department of Medical Oncology, Kinki University, Osakasayama, Osaka Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka taroh@cfs.med.osaka-u.ac.jp.

Show MeSH
Related in: MedlinePlus